Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%

Serious adverse events · Adult patients with active ulcerative colitis

Budesonide MMX® 6 mg showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.63 [0.21, 1.91]
2 studies · 512 participants
Low

Serious adverse events · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in serious adverse events compared with entocort EC 9mg (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 3.94 [0.45, 34.74]
1 study · 254 participants
Low

Serious adverse events · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.88 [0.33, 2.4]
2 studies · 513 participants
Low